All News

The FDA granted accelerated approval to Immunomedics’ Trodelvy (sacituzumab govitecan-hziy) as the first antibody-drug conjugate that targets the Trop-2 antigen. Trodelvy is indicated for treatment of relapsed or refractory metastatic triple-negative breast cancer (TNBC) that has spread to other parts of the body.

Visual impairment may be a risk factor for dementia, according to a study published in JAMA Ophthalmology in which researchers compared the likelihood of incident dementia or mild cognitive impairment among women with and without baseline visual impairment.

Nearly 5 in 10 individuals in the United States—150 million Americans—live where pollution levels are often too dangerous to breathe, according to the American Lung Association’s annual State of the Air Report, released today. Poor air quality has been linked to higher rates of chronic diseases, comorbidities, and poor health outcomes. Several studies suggest poor air quality is a contributing factor to the prevalence of coronavirus disease 2019 (COVID-10) in some communities.

CMS will allow clinicians who participate in the Quality Payment Program to earn credit in the Merit-based Incentive Payment System (MIPS) for participation in a coronavirus disease 2019 (COVID-19) clinical trial and reporting clinical information; President Trump announced via Twitter that he would sign an executive order to temporarily suspend immigration; findings from antibody testing in Los Angeles indicate that more people have been infected with COVID-19 than initially confirmed.

In the eligibility terms and conditions published by HHS for practices seeking emergency funding, surprise medical billing is banned for patients with the coronavirus disease 2019 (COVID-19); more Americans are worried the United States will lift restrictions on the pandemic too soon than they are about the economic shutdown; nursing homes are now required to report cases of COVID-19 to the CDC.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo